Genocea Biosciences reported $12.38M in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Agenus AGEN:US $ 3.42M 12.3M
Baxter International BAX:US $ 8859M 216M
Bluebird Bio BLUE:US $ 180.12M 83.14M
Cytokinetics CYTK:US $ 111.41M 4.85M
Cytori Therapeutics CYTX:US $ 9.68M 4.96M
Genocea Biosciences GNCA:US $ 12.38M 14.69M
Glaxosmithkline GSK:US $ 16374M 193M
Infinity Pharmaceuticals INFI:US $ -1.11M 11.09M
Moderna Inc MRNA:US 17.98B 910M
Novavax NVAX:US $ -416.95M 482.27M
Prothena PRTA:US $ 407.3M 31.59M